Key facts
- This page summarizes Peter D.o. Donhauser's Form 4 filing for ANAVEX LIFE SCIENCES CORP. (AVXL).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 17 Jun 2024, 07:30.
Peter D.o. Donhauser - 14 Jun 2024 Form 4 Insider Report for ANAVEX LIFE SCIENCES CORP. (AVXL)
- Reporting relationship
- Director
- Issuer ticker
- AVXL
- Reported as of
- 14 Jun 2024
- Net transaction value
- +$10,319
- SEC form
- 4
- Accepted by SEC
- 17 Jun 2024, 07:30:10 UTC
- Prior SEC filing
- 23 Feb 2024
- Next SEC filing
- 02 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/Peter Donhauser
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Peter D.o. Donhauser filed Form 4 for ANAVEX LIFE SCIENCES CORP. (AVXL) on 17 Jun 2024.
Change
- Previous filing in this sequence was filed on 23 Feb 2024.
- Current net transaction value: +$10,319.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AVXL
transaction
Common Stock
Purchase
- Transaction value
- $10,319
- Shares
- +2,835
- Change %
- +131%
- Price
- $3.64
- Shares after
- 5,000
- Date
- 14 Jun 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Purchase price denominated in Euros has been translated to US dollars using an exchange rate of 0.936